The global prosthetics and orthotics market size was USD 8.38 billion in 2023, estimated at USD 8.79 billion in 2024 and is anticipated to reach around USD 13.94 billion by 2034, expanding at a CAGR of 4.72% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Prosthetics And Orthotics Market, by Product Type, 2024-2034
7.1.1. Orthotics
7.1.1.1. Upper Limb
7.1.1.2. Lower Limb
7.1.1.3. Spinal Orthotics
7.1.1.4. Market Revenue and Forecast (2021-2034)
7.1.2. Prosthetics
7.1.2.1. Upper Extremity
7.1.2.2. Lower Extremity
7.1.2.3. Liners
7.1.2.4. Sockets
7.1.2.5. Modular Components
7.1.2.6. Market Revenue and Forecast (2021-2034)
8.1. North America
8.1.1. Market Revenue and Forecast, by Product (2021-2034)
8.1.2. U.S.
8.1.3. Rest of North America
8.1.3.1. Market Revenue and Forecast, by Product (2021-2034)
8.2. Europe
8.2.1. Market Revenue and Forecast, by Product (2021-2034)
8.2.2. UK
8.2.2.1. Market Revenue and Forecast, by Product (2021-2034)
8.2.3. France
8.2.3.1. Market Revenue and Forecast, by Product (2021-2034)
8.2.4. Rest of Europe
8.2.4.1. Market Revenue and Forecast, by Product (2021-2034)
8.3. APAC
8.3.1. Market Revenue and Forecast, by Product (2021-2034)
8.3.2. India
8.3.2.1. Market Revenue and Forecast, by Product (2021-2034)
8.3.3. China
8.3.3.1. Market Revenue and Forecast, by Product (2021-2034)
8.3.4. Japan
8.3.4.1. Market Revenue and Forecast, by Product (2021-2034)
8.3.5. Rest of APAC
8.3.5.1. Market Revenue and Forecast, by Product (2021-2034)
8.4. MEA
8.4.1. Market Revenue and Forecast, by Product (2021-2034)
8.4.2. GCC
8.4.2.1. Market Revenue and Forecast, by Product (2021-2034)
8.4.3. North Africa
8.4.3.1. Market Revenue and Forecast, by Product (2021-2034)
8.4.4. South Africa
8.4.4.1. Market Revenue and Forecast, by Product (2021-2034)
8.4.5. Rest of MEA
8.4.5.1. Market Revenue and Forecast, by Product (2021-2034)
8.5. Latin America
8.5.1. Market Revenue and Forecast, by Product (2021-2034)
8.5.2. Brazil
8.5.2.1. Market Revenue and Forecast, by Product (2021-2034)
8.5.3. Rest of LATAM
8.5.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.1. Ossur
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Fillauer LLC
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. Ottobock Healthcare GmbH
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. Blatchford Inc.
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. Ultraflex Systems Inc.
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Shapeways, Inc.
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. Hanger, Inc.
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
9.8. Bauerfeind AG
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives
10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions
11.1. About Us
11.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client